HTG Molecular

HTG Transcriptome
Panel Available Now

Simplify gene expression analysis with our new comprehensive human transcriptome panel.

Learn More
VERI/O Laboratory Services

It's not business, it's personal.
We treat our partners like colleagues and your study like our own.

Learn More
HTG EdgeSeq Panels

The most fragile RNA samples can now reveal the greatest insights for gene expression and biomarker discovery.

Learn More
HTG EdgeSeq Systems

Devlivering extraction-free RNA molecular profiling solutions and semi-automated library prep.

Learn More

Harness the Power of HTG's Proprietary Transcriptome Panel

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's RNA platform technologies make the development of life science tools and diagnostics more effective and cost-efficient, enabling researchers to interrogate the entire transcriptome with smaller sample requirements and higher success rates.

Featured Publication

Overview of the Design and Performance of the HTG Transcriptome Panel

This White Paper summarizes the data generated using the HTG Transcriptome Panel from Feasibility through Verification, including comparison to RNA-Seq.

READ PUBLICATION

HTG Molecular News & Events

The Festival of Genomics & Biodata 2023

January 25-26, 2023 | Come and see us in London at the 2023 Festival of Genomics

Category:
Future Events

Posted on: 04-29-2022

Keep Reading

HTG Technology Featured Across Numerous Abstracts at Upcoming Scientific Conferences

TUCSON, Ariz. , Dec. 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced there will be at least eight…

Category:
Press Releases

Keep Reading

HTG Molecular Diagnostics Reports Third Quarter 2022 Results

TUCSON, Ariz. , Nov. 10, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today reported financial results for the…

Category:
Press Releases

Keep Reading

HTG to Collaborate With OmiCure, Providing Transcriptomic Data Across Several Cancer Indications

TUCSON, Ariz. and PARIS , Oct. 26, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, and OmiCure ® , a leading European digital health company that…